Detalhe da pesquisa
1.
Boarding is associated with higher rates of medication delays and adverse events but fewer laboratory-related delays.
Am J Emerg Med
; 32(9): 1033-6, 2014 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-25027202
2.
CT53518, a novel selective FLT3 antagonist for the treatment of acute myelogenous leukemia (AML).
Cancer Cell
; 1(5): 421-32, 2002 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-12124172
3.
PKC412 overcomes resistance to imatinib in a murine model of FIP1L1-PDGFRα-induced myeloproliferative disease.
Cancer Cell
; 3(5): 459-69, 2003 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-12781364
4.
Altered mental status and tachycardia.
J Emerg Med
; 48(5): 597-602, 2015 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-25656429
5.
Epigenetic silencing of novel tumor suppressors in malignant melanoma.
Cancer Res
; 66(23): 11187-93, 2006 Dec 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-17145863
6.
FLT3 internal tandem duplication mutations induce myeloproliferative or lymphoid disease in a transgenic mouse model.
Oncogene
; 24(53): 7882-92, 2005 Nov 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-16116483
7.
mTORC1 activation blocks BrafV600E-induced growth arrest but is insufficient for melanoma formation.
Cancer Cell
; 27(1): 41-56, 2015 Jan 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-25584893
8.
ß-catenin signaling controls metastasis in Braf-activated Pten-deficient melanomas.
Cancer Cell
; 20(6): 741-54, 2011 Dec 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-22172720
9.
Characterization of melanoma cells capable of propagating tumors from a single cell.
Cancer Res
; 70(1): 388-97, 2010 Jan 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-20048081
10.
Braf(V600E) cooperates with Pten loss to induce metastatic melanoma.
Nat Genet
; 41(5): 544-52, 2009 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-19282848
11.
Characterization of melanocyte-specific inducible Cre recombinase transgenic mice.
Genesis
; 44(5): 262-7, 2006 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-16676322
12.
Loss of Runx1 perturbs adult hematopoiesis and is associated with a myeloproliferative phenotype.
Blood
; 106(2): 494-504, 2005 Jul 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-15784726
13.
PML/RARalpha and FLT3-ITD induce an APL-like disease in a mouse model.
Proc Natl Acad Sci U S A
; 99(12): 8283-8, 2002 Jun 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-12060771
14.
Variable sensitivity of FLT3 activation loop mutations to the small molecule tyrosine kinase inhibitor MLN518.
Blood
; 104(9): 2867-72, 2004 Nov 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-15256420
15.
A new mechanism of release from senescence: suppression of p16INK4a by beta-catenin.
Pigment Cell Melanoma Res
; 21(1): 5-6, 2008 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-18353136